SCHEMBL19360604

SCHEMBL19360604

CCn1c(Cc2ccc(OC(F)(F)F)cc2)cc2cc(C(=O)O)ccc21

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 6/20 0.47
CNR2 P34972 1/20 0.44
MRGPRX4 Q96LA9 1/20 0.44
RORC P51449 4/20 0.44
NTRK1 P04629 2/20 0.42
PTGER4 P35408 1/20 0.40
KDM5A P29375 1/20 0.39
KDM2B Q8NHM5 1/20 0.39
KDM4C Q9H3R0 1/20 0.39
KDM5B Q9UGL1 1/20 0.39
PPARA Q07869 1/20 0.39
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19360605 0.90 IDH1 (0.47) IDH1CNR2MRGPRX4RORC
SCHEMBL28197165 0.87 IDH1 (0.48) IDH1CNR2MRGPRX4NTRK1KDM5A
SCHEMBL18440701 0.85 RORC (0.55) IDH1RORC
SCHEMBL28197905 0.84 RORC (0.50) IDH1CNR2MRGPRX4RORC
SCHEMBL20465147 0.83 SRD5A2 (0.48) IDH1RORC
SCHEMBL18440704 0.82 RORC (0.53) RORC
SCHEMBL28197169 0.81 IDH1 (0.51) IDH1MRGPRX4RORC
SCHEMBL19360598 0.81 EPHX2 (0.48) RORCPPARA
SCHEMBL19360602 0.81 RORC (0.62) RORC
SCHEMBL19360401 0.79 RORC (0.51) MRGPRX4RORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107531679-B Aromatic amide derivative, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2021-07-02 CN disclosed
CN-107531679-A Aromatic amides analog derivative, its preparation method and its application in medicine 江苏恒瑞医药股份有限公司 2018-01-02 CN disclosed
WO-2017157332-A1 AROMATIC AMIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL APPLICATIONS THEREOF 江苏恒瑞医药股份有限公司 2017-09-21 WO disclosed